442 related articles for article (PubMed ID: 11449204)
1. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children.
Boner AL
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S32-9. PubMed ID: 11449204
[TBL] [Abstract][Full Text] [Related]
2. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM
J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
Patel D; Ratner P; Clements D; Wu W; Faris M; Philpot E
Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
[TBL] [Abstract][Full Text] [Related]
5. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
[TBL] [Abstract][Full Text] [Related]
6. Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis.
Brannan MD; Herron JM; Reidenberg P; Affrime MB
Clin Ther; 1995; 17(4):637-47. PubMed ID: 8565027
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
8. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function, part I: general overview of HPA axis study design.
Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
J Pharm Sci; 2013 Oct; 102(10):3513-27. PubMed ID: 23918409
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone propionate: topical or systemic effects?
Howland WC
Clin Exp Allergy; 1996 May; 26 Suppl 3():18-22. PubMed ID: 8735854
[TBL] [Abstract][Full Text] [Related]
10. Lysine-vasopressin in the evaluation of the hypothalamic-pituitary-adrenal axis in children with allergic rhinitis treated with intranasal beclomethasone dipropionate or oral prednisone.
Kokron CM; Castro AS; Solé D; Naspitz CK
J Investig Allergol Clin Immunol; 1997; 7(1):51-6. PubMed ID: 9093935
[TBL] [Abstract][Full Text] [Related]
11. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
[TBL] [Abstract][Full Text] [Related]
12. Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner.
Grebe SK; Feek CM; Durham JA; Kljakovic M; Cooke RR
Clin Endocrinol (Oxf); 1997 Sep; 47(3):297-304. PubMed ID: 9373450
[TBL] [Abstract][Full Text] [Related]
13. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis.
Hampel FC; Nayak NA; Segall N; Small CJ; Li J; Tantry SK
Ann Allergy Asthma Immunol; 2015 Aug; 115(2):137-42. PubMed ID: 26250771
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children.
Brannan MD; Herron JM; Affrime MB
Clin Ther; 1997; 19(6):1330-9. PubMed ID: 9444443
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
Wilson AM; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799
[TBL] [Abstract][Full Text] [Related]
16. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
Onrust SV; Lamb HM
Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients.
Galant SP; Melamed IR; Nayak AS; Blake KV; Prillaman BA; Reed KD; Cook CK; Philpot EE; Rickard KA
Pediatrics; 2003 Jul; 112(1 Pt 1):96-100. PubMed ID: 12837873
[TBL] [Abstract][Full Text] [Related]
18. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids.
Brown PH; Blundell G; Greening AP; Crompton GK
Respir Med; 1991 Nov; 85(6):511-6. PubMed ID: 1775678
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids.
Brown PH; Blundell G; Greening AP; Crompton GK
Respir Med; 1991 Nov; 85(6):501-10. PubMed ID: 1775677
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.
Meltzer EO; Tripathy I; Máspero JF; Wu W; Philpot E
Clin Drug Investig; 2009; 29(2):79-86. PubMed ID: 19133703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
